Marco Silvestri

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Venues

Cancers

International journal of molecular sciences

Disease markers

Scientific reports

Fondazione IRCCS Istituto Nazionale dei Tumori

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fondazione IRCCS Istituto Nazionale dei Tumori Jul 01 2017

Italy

Research fellow :: Applied research and technological development

Publications

Marco Silvestri, Trung Nghia Vu, Federico Nichetti, Monica Niger, Serena Di Cosimo, Filippo De Braud, Giancarlo Pruneri, Yudi Pawitan, Stefano Calza, Vera Cappelletti
Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma. Cancer medicine (2023)
Marco Silvestri, Carolina Reduzzi, Giancarlo Feliciello, Marta Vismara, Thomas Schamberger, Cäcilia Köstler, Rosita Motta, Stefano Calza, Cristina Ferraris, Andrea Vingiani, Giancarlo Pruneri, Maria Grazia Daidone, Christoph A Klein, Bernhard Polzer, Vera Cappelletti
Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients. Cancers 13 (6) (2021)
Chiara Romani, Davide Capoferri, Elisabetta Grillo, Marco Silvestri, Michela Corsini, Laura Zanotti, Paola Todeschini, Antonella Ravaggi, Eliana Bignotti, Franco Edoardo Odicino, Enrico Sartori, Stefano Calza, Stefania Mitola
The Claudin-Low Subtype of High-Grade Serous Ovarian Carcinoma Exhibits Stem Cell Features. Cancers 13 (4) (2021)
Serena Di Cosimo, Valentina Appierto, Sara Pizzamiglio, Marco Silvestri, José Baselga, Martine Piccart, Jens Huober, Miguel Izquierdo, Lorena de la Pena, Florentine S Hilbers, Evandro de Azambuja, Michael Untch, Lajos Pusztai, Kathleen Pritchard, Paolo G Nuciforo, Anne Vincent-Salomon, Fraser Symmans, Giovanni Apolone, Filippo G de Braud, Marilena V Iorio, Paolo Verderio, Maria Grazia Daidone
Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy. International journal of molecular sciences 21 (4) (2020)
Vera Cappelletti, Elena Verzoni, Raffaele Ratta, Marta Vismara, Marco Silvestri, Rosanna Montone, Patrizia Miodini, Carolina Reduzzi, Melanie Claps, Pierangela Sepe, Maria Grazia Daidone, Giuseppe Procopio
Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression. International journal of molecular sciences 21 (4) (2020)
Serena Di Cosimo, Valentina Appierto, Marco Silvestri, Giancarlo Pruneri, Andrea Vingiani, Federica Perrone, Adele Busico, Secondo Folli, Gianfranco Scaperrotta, Filippo Guglielmo de Braud, Giulia Valeria Bianchi, Stefano Cavalieri, Maria Grazia Daidone, Matteo Dugo
Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity before and after Neoadjuvant Chemotherapy. Cancers 11 (11) (2019)
Woochang Hwang, Stefano Calza, Marco Silvestri, Yudi Pawitan, Youngjo Lee
CREDO: Highly confident disease-relevant A-to-I RNA-editing discovery in breast cancer. Scientific reports 9 (1) (2019)
Vera Cappelletti, Egidio Iorio, Patrizia Miodini, Marco Silvestri, Matteo Dugo, Maria Grazia Daidone
Metabolic Footprints and Molecular Subtypes in Breast Cancer. Disease markers 2017 (2017)

Marco Silvestri.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marco Silvestri